Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $28.91

Privia Health Group, Inc. (NASDAQ:PRVA) has received an average recommendation of “Moderate Buy” from the fourteen research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $28.9091.

A number of brokerages have recently commented on PRVA. Barclays upped their target price on shares of Privia Health Group from $21.00 to $22.00 and gave the company an “equal weight” rating in a report on Thursday, October 9th. Stephens restated an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research report on Wednesday, September 24th. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. JMP Securities lifted their target price on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research note on Friday, August 29th. Finally, Piper Sandler dropped their target price on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently bought and sold shares of the company. Public Sector Pension Investment Board boosted its holdings in shares of Privia Health Group by 25.9% in the third quarter. Public Sector Pension Investment Board now owns 450,010 shares of the company’s stock valued at $11,205,000 after acquiring an additional 92,507 shares in the last quarter. Illinois Municipal Retirement Fund lifted its position in Privia Health Group by 1.1% in the third quarter. Illinois Municipal Retirement Fund now owns 55,501 shares of the company’s stock valued at $1,382,000 after purchasing an additional 585 shares during the period. Rhumbline Advisers lifted its position in Privia Health Group by 2.9% in the third quarter. Rhumbline Advisers now owns 328,470 shares of the company’s stock valued at $8,179,000 after purchasing an additional 9,310 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Privia Health Group by 37.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 12,398 shares of the company’s stock valued at $303,000 after purchasing an additional 3,373 shares in the last quarter. Finally, Van Berkom & Associates Inc. increased its position in Privia Health Group by 30.1% during the 3rd quarter. Van Berkom & Associates Inc. now owns 3,774,565 shares of the company’s stock worth $93,987,000 after purchasing an additional 873,344 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Trading Down 4.2%

Shares of NASDAQ PRVA opened at $23.98 on Tuesday. The stock has a market cap of $2.94 billion, a P/E ratio of 218.02, a P/E/G ratio of 3.41 and a beta of 0.83. Privia Health Group has a twelve month low of $18.77 and a twelve month high of $26.51. The stock has a 50 day moving average of $24.14 and a two-hundred day moving average of $22.76.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The business had revenue of $213.61 million for the quarter. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. As a group, research analysts predict that Privia Health Group will post 0.14 earnings per share for the current year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.